Abstract 10926: Warfarin Dosing Algorithms With the Information on Genotype and Amiodarone for Patients Without Extracorporeal Circulation Devices Could Be Beneficial for Those With Left Ventricular Assist Devices
Misaki Makiguchi(The University of Osaka), Yasushi Fujio(Hyogo University of Health Sciences), Takaaki Samura(Fukui CardioVascular Center), Fusako Sera(The University of Osaka), Toshihiro Takeda(Osaka City University), Yoshito Ito(Kyoto Prefectural University of Medicine), Shigeru Miyagawa(The University of Osaka), Yoshiki Sawa(Osaka Police Hospital), Yasushi Sakata(Osaka University), Makiko Maeda(The University of Osaka), Satoshi Kainuma(National Cerebral and Cardiovascular Center), Ai Kawamura(Max Planck Institute for Heart and Lung Research), Daisuke Yoshioka(The University of Osaka), Noriyuki Kashiyama(The University of Osaka), Shinichiro Maeda(The University of Osaka), Kaoru Kubota(The University of Osaka), Tomohito Ohtani(The University of Osaka), Marika Saito(The University of Osaka), Takuji Kawamura(The University of Osaka)
Cited by 0
Related Papers
The SGLT2 inhibitor empagliflozin in patients hospitalized for acute heart failure: a multinational randomized trial
|Nature Medicine|2022|889
Large-scale genome-wide association study in a Japanese population identifies novel susceptibility loci across different diseases
|Nature Genetics|2020|599
In vivo transfection of cis element “decoy” against nuclear factor- κB binding site prevents myocardial infarction
|Nature Medicine|1997|589
Hepatocyte growth factor gene therapy of liver cirrhosis in rats
|Nature Medicine|1999|588
JCS/JSCS/JATS/JSVS 2020 Guidelines on the Management of Valvular Heart Disease
|Circulation Journal|2020|363